Form 4 for BJDX Bluejay Diagnostics, Inc.
Accepted 2023-12-14 00:00:00 ET · period of report 2023-12-13 · accession 0001062993-23-022568 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12-14 | 2023-12-13 | BJDX | Dey Indranil | Pres, CEO, Dir, 10% | P - Purchase | $3.27 | +500 | 28.5K | +2% | +$1,635 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-13 | P | A | 500 | $3.27 | 28,526 | D | — | — |